Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

17 February 2026

Op-ed: How AI can help bridge healthcare gaps worldwide

For World Economic Forum, the Access to Medicine Foundation’s CEO Jayasree K. Iyer explains how AI can be leveraged to solve barriers to access to medicine and improving care in low- and middle-income countries.

Direct links

Read the full op-ed

In a World Economic Forum article, Jayasree K. Iyer, CEO of the Access to Medicine Foundation, explores how artificial intelligence is reshaping healthcare, from clinical decision support to supply chain management.

With tech giants such as Google, Microsoft and Amazon now investing heavily in health AI, there is potential to improve care in low- and middle-income countries (LMICs). Yet without action, these advances could reinforce – not reduce – global health inequities, Jayasree says.

AI tools are already helping clinicians make faster decisions and accelerating drug discovery. Initiatives backed by the Gates Foundation and OpenAI aim to expand access in Africa, beginning in Rwanda. However, major barriers remain.

Africa holds just 1.3% of global data-storage capacity, limiting compute power, while regulatory fragmentation and strict data-governance rules complicate deployment. A persistent data-representation gap, particularly in African languages, further risks excluding billions from AI-driven care, Jayasree writes.

She concludes that AI could transform global health, but equity will depend on inclusive design, infrastructure investment and a clear commitment from Big Tech to share the benefits more fairly.

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

In the Media

Read other op-eds by Jayasree K. Iyer

Op-ed: Smart policies, not more dependence, will boost Africa’s health financing

12 November 2025
Media

Op-ed: Demand for treatment for type 1 and type 2 diabetes has never been higher

07 October 2025
Media

Op-ed: Improving access to innovative medicines in Africa starts with clinical trials

09 July 2025

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved